George Washington University Hematology Update Symposium 2025

• Target Audience: hematologists/oncologists, hospitalists, internists
• Sample video: contact me for sample video
• Information:

A concentrated, practice-focused update covering both benign and malignant hematology. Case-based lectures translate the latest evidence and guidelines into clear diagnostic pathways, treatment algorithms, and toxicity management you can apply immediately in clinic, hospital, and infusion settings.

What You Will Learn

Streamlined workups for anemia, cytopenias, coagulopathies, and thrombophilias

Evidence-based VTE care: anticoagulant selection, duration, peri-procedural management

Current standards and emerging options in leukemia, lymphoma, and myeloma

Transfusion medicine pearls: product selection, thresholds, reactions, and stewardship

Targeted agents and immunotherapies (BTK/BCL2 inhibitors, bispecifics, CAR-T): when to use and how to manage adverse events

Supportive care essentials: infection prophylaxis, tumor lysis risk mitigation, survivorship, and quality measures

Event Details

Format: Live, case-based lectures with board-style Q&A and practical take-home checklists

Structure: Thematic sessions (benign, malignant, thrombosis/hemostasis, transfusion, supportive care) with concise summaries for rapid reference

Access: Designed for quick implementation in community and academic settings

Who Should Attend

Hematologists/oncologists, hospitalists, internists, advanced practice providers, pharmacists, fellows/trainees, and infusion-center leaders seeking a high-yield, clinically oriented hematology refresh.

Why Attend

Convert complex trials and guidelines into simple, usable algorithms

Update diagnostics, therapeutics, and toxicity management across the hematology spectrum

Leave with pragmatic tools that improve safety, efficiency, and patient outcomes

• Topics:

Saturday, February 15, 2025- Hyatt Regency Bethesda- Salons I-II

File

TIME

TOPIC

PRESENTER

Breakfast | Visit Exhibit Hall- Salon III-IV

Exhibitors | Attendees

1

Welcome | Introduction to Program

Robert S. Siegel, MD

Professor of Medicine, Associate Center Director for Education and Training,

The George Washington University, GW Cancer Center

2

Myeloproliferative Neoplasms

Ayalew Tefferi, MD

Barbara Woodward Lips Professor of Medicine

Mayo Clinic

3

Multiple Myeloma

Kenneth Anderson, MD

Kraft Family Professor of Medicine

Dana-Farber Cancer Institute,

Harvard Medical School

Break | Visit Exhibit Hall- Salon III-IV

Exhibitors | Attendees

4

Disorders of Coagulation

Kenneth A. Bauer, MD

Professor of Medicine, Harvard Medical School

Beth Israel Deaconess Medical Center

5

Acute Myeloid Leukemia

Samah Nassereddine, MD

Assistant Professor of Medicine, The George Washington University, GW Cancer Center

6

Chronic Lymphocytic Leukemia

Imad A. Tabbara, MD, FACP

Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute,

Anne Arundel Medical Center, Clinical Professor of Medicine

George Washington University

Lunch | Visit Exhibit Hall- Salon III-IV

Exhibitors | Attendees

Lunch Product Forum sponsored by (tbc)

7

Lymphoma

Nina Delaney Wagner-Johnston, MD

Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine

8

Bone Marrow Failure

Mrinal S. Patnaik, MD

Chair, Acute Leukemia and Myeloid Neoplasms

Scientific Director of the Epigenetics Developmental Laboratory and Epigenomics Program

Associate Professor of Medicine

College of Medicine, Mayo Clinic

9

Chronic Myelomonocytic Leukemia

Ayalew Tefferi, MD

Barbara Woodward Lips Professor of Medicine

Mayo Clinic

10

Closing Remarks | Adjournment

Robert S. Siegel, MD

Professor of Medicine, Associate Center Director for Education and Training,

The George Washington University, GW Cancer Center